Results 11 to 20 of about 312,210 (374)

Chagas disease [PDF]

open access: yesLancet, The, 2023
Chagas disease persists as a global public health problem due to the high morbidity and mortality burden. Despite the possibility of a cure and advances in transmission control, epidemiological transformations, such as urbanisation and globalisation, and the emerging importance of oral and vertical transmission mean that Chagas disease should be ...
Billick MJ, Silverberg SL.
exaly   +6 more sources

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases

open access: yesFrontiers in Chemistry, 2021
Neglected tropical diseases (NTDs) as termed by WHO include twenty different infectious diseases that are caused by bacteria, viruses, and parasites. Among these NTDs, Chagas disease and leishmaniasis are reported to cause high mortality in humans and ...
Brindha J   +2 more
doaj   +2 more sources

Genetic Variants Associated with Life Expectancy in Patients with Chagas Disease [PDF]

open access: yesMedical Sciences
Single nucleotide polymorphisms (SNPs), as common genetic variations, can influence biological processes. Identifying these variations is crucial for recognizing high-risk subgroups, guiding preventive strategies, and enabling personalized management ...
Mario Bruno Principato   +10 more
doaj   +2 more sources

Formas clínicas y diagnóstico de la enfermedad de Chagas e inmunosupresores

open access: diamondRevista Argentina de Reumatología, 2019
La enfermedad de Chagas constituye una infección severa de alta prevalencia en Argentina y otros países latinoamericanos. La administración de drogas reumáticas inmunosupresoras en estos pacientes, muchas veces es necesaria, pero no se conoce aún la ...
Darío Scublinsky   +4 more
doaj   +3 more sources

The Learning Curve for Peroral Endoscopic Myotomy in Latin America: A Slide to the Right? [PDF]

open access: yesClinical Endoscopy, 2021
Background/Aims Peroral endoscopic myotomy (POEM) has been increasingly used for achalasia in Latin America, where Chagas disease is prevalent, and this makes POEM more challenging.
Michel Kahaleh   +23 more
doaj   +1 more source

Seroprevalencia de la enfermedad de Chagas (Trypanosoma cruzi) en la población escolar e incidencia parasitaria de Triatoma dimidiata en la parroquia Juan Gómez Rendón, Provincia del Guayas, Ecuador

open access: yesRevista Científica de Ciencias Naturales y Ambientales, 2021
Se realizaron encuestas serológicas y entomológicas para determinar la prevalencia de la enfermedad de Chagas, la presencia del vector y el índice tripano triatomino, en la población escolar de la parroquia Juan Gómez Rendón, en la provincia del Guayas,
Verónica Calderón, Jaime Buestán
doaj   +1 more source

In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches

open access: yesPharmaceuticals, 2022
Chagas and leishmaniasis are two neglected diseases considered as public health problems worldwide, for which there is no effective, low-cost, and low-toxicity treatment for the host.
Lina S. Prieto Cárdenas   +6 more
doaj   +1 more source

Epidemiologia de Triatominos en la Provincia de Río Negro

open access: yesCiencia Veterinaria, 2021
Chagas es una enfermedad endemoepidémica de transmisión vec-torial en la Provincia de Rio Negro causada por Trypanosoma cruzi, transmitido por insectos vectores denominados triatominos (vinchu-cas).
Crowley P   +9 more
doaj   +1 more source

Chagas Disease [PDF]

open access: yesPediatrics In Review, 2016
Approximately 8 million people worldwide are infected by the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease. After a latent period that can last years or decades, 10% to 30% of infected people develop serious complications, such as cardiomyopathy or gastrointestinal dysfunction.
Tustin, Aaron W., Bowman, Natalie M.
openaire   +2 more sources

Home - About - Disclaimer - Privacy